Page last updated: 2024-11-05

tetraethylammonium and Hamartoma

tetraethylammonium has been researched along with Hamartoma in 1 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, J1
Xu, L1
Kim, DY1
Rho, JM1
St John, PA1
Lue, LF1
Coons, S1
Ellsworth, K1
Nowak, L1
Johnson, E1
Rekate, H1
Kerrigan, JF1

Other Studies

1 other study available for tetraethylammonium and Hamartoma

ArticleYear
Electrophysiological properties of human hypothalamic hamartomas.
    Annals of neurology, 2005, Volume: 58, Issue:3

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adolescent; Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolep

2005